US LNG exports surge but will buyers in China turn up?
Semler Scientific, Inc. (NASDAQ:SMLR), a healthcare technology company with a market capitalization of $584.63 million and impressive gross profit margins of 91%, reported Thursday that it anticipates an unrealized gain of approximately $83.8 million from the change in fair value of its Bitcoin holdings for the quarter ended June 30, 2025. According to InvestingPro data, the company’s financial health score is rated as "GOOD," despite facing some liquidity challenges with a current ratio of 0.52. The company corrected its previously reported Bitcoin valuation, now using a price of about $107,176 per Bitcoin instead of $108,621, as stated in a press release and SEC filing.
The company noted that its financial results for the second quarter are preliminary and unaudited, with closing procedures still ongoing. The information may be subject to change upon completion of the review process. With the next earnings report scheduled for August 11, 2025, investors can access comprehensive analysis through InvestingPro’s detailed research reports, which provide deeper insights into the company’s performance metrics and future outlook.
Between July 3 and July 16, Semler Scientific acquired 210 Bitcoin for roughly $25.0 million, with an average purchase price of $118,974 per Bitcoin, including fees and expenses. As of July 16, the company held 4,846 Bitcoin, acquired at a total cost of approximately $455.0 million and an average price of $93,890 per Bitcoin. The market value of these holdings was about $577.9 million, based on the Coinbase (NASDAQ:COIN) exchange price at 4:00 p.m. ET on July 16.
Semler Scientific also provided an update on its at-the-market (ATM) stock offering program. As of July 16, the company had issued and sold 4,466,449 shares of common stock, generating net proceeds of approximately $175.0 million under its sales agreement with several financial institutions. The company’s current valuation metrics suggest it may be trading above its Fair Value, according to InvestingPro’s proprietary analysis, while maintaining a debt-to-equity ratio of 0.59.
The company reported a year-to-date BTC Yield, a key performance indicator for its Bitcoin strategy, of 30.3% through July 16.
Semler Scientific maintains a dashboard on its website to provide public updates on its Bitcoin holdings and related metrics. The company stated that some of this information may be considered material and intends to use the dashboard to comply with disclosure obligations.
All data in this article is based on statements from the company’s press release and SEC filing, complemented by financial metrics from InvestingPro, which offers 12 additional key insights about Semler Scientific’s performance and outlook through its comprehensive Pro Research Reports, available for over 1,400 US stocks.
In other recent news, Semler Scientific has been active with several notable developments. The company reported raising approximately $114.8 million through an at-the-market offering, issuing over three million shares of common stock. This capital has been partly allocated to acquire 455 Bitcoin, bringing Semler’s total Bitcoin holdings to 4,264, valued at $474.4 million. Benchmark has reiterated a Buy rating on Semler Scientific with a price target of $101, highlighting the company’s strategic pivot to include Bitcoin as a primary treasury reserve asset.
In addition, Semler Scientific has announced the formation of a new subsidiary, CardioVanta, which will focus on early detection of heart failure and cardiac arrhythmia monitoring. CardioVanta will operate as a software-as-a-service business model and seek external investment to support its growth. The company plans to continue marketing its QuantaFlo device while expanding into the cardiac health monitoring market. Semler’s strategy reflects its dual focus on medical technology and cryptocurrency investments.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.